aldo-keto reductase family 1 member C3; prostaglandin F synthase; PGFS; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase; 3-alpha-hydroxysteroid dehydrogenase type 2; 3-alpha-HSD type 2; 3-alpha-HSD type II, brain; testosterone 17-beta-dehydrogenase 5; 17-beta-hydroxysteroid dehydrogenase type 5; 17-beta-HSD 5; dihydrodiol dehydrogenase type I; dihydrodiol dehydrogenase 3; DD-3; DD3; chlordecone reductase homolog HAKRb; HA1753 (AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS)
Jump to navigation
Jump to search
Function
- catalyzes the conversion of aldehydes & ketones to alcohols
- catalyzes reduction of prostaglandin PGD2, PGH2 & phenanthrenequinone & oxidation of 9-alpha,11-beta-PGF2 to PGD2
- functions as a bi-directional 3-alpha-, 17-beta- & 20-alpha hydroxysteroid dehydrogenase
- dominant hydroxysteroid dehydrogenase in prostate & mammary gland
- can interconvert active androgens, estrogens & progestins with their cognate inactive metabolites
- preferentially transforms androstenedione (4-dione) to testosterone
- strongly inhibited by nonsteroidal anti-inflammatory drugs including flufenamic acid & indomethacin
- also inhibited by the flavinoid, rutin, & by selective serotonin inhibitors (SSRIs)
- KM=142.1 uM for progesterone
- KM=2.37 uM for 5-alpha-dihydrotestosterone
- KM=1.0 uM for androstanediol
- Vmax=20.1 nmol/min/mg enzyme with progesterone as substrate
- Vmax=1.8 nmol/min/mg enzyme with 5-alpha-dihydrotestosterone as substrate
- Vmax=4.4 nmol/min/mg enzyme with androstanediol as substrate
trans-1,2-dihydrobenzene-1,2-diol + NADP+ <--> catechol + NADPH ; androsterone + NAD+/NADP+ <--> 5-alpha-androstane-3,17-dione + NADH/NADPH
(5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ <--> (5Z,13E)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADPH
testosterone + NAD+ <--> androst-4-ene-3,17-dione + NADH
testosterone + NADP+ <--> androst-4-ene-3,17-dione + NADPH
Structure
belongs to the aldo/keto reductase family
Compartment
Expression
- expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate & testis
- in the prostate, higher levels in epithelial cells than in stromal cells
- in the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei & amygdala; weaker expression in the hippocampus, substantia nigra & caudate